National Ferret Resource and Research Center on Lung Disease
National Ferret Resource and Research Center on Lung Disease
批准号:
8751112
负责人:
JOHN F ENGELHARDT
金额:
$83.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-05-31
关键词:
AffectAgeAlternative TherapiesAnatomyAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesBirthBloodBoxingBronchiectasisBusinessesCatalogingCatalogsCaucasiansCaucasoid RaceCell TherapyCellsCellular biologyChromosomesChronicCommunitiesComplementary DNACystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDatabasesDepositionDiseaseDisease ProgressionDisease modelDisease susceptibilityEffectivenessEnzyme-Linked Immunosorbent AssayFerretsFunctional disorderFundingGene ProteinsGene TargetingGenerationsGeneticGenetic DriftGenetic EngineeringGenetic ModelsGenomeGenomicsGoalsHeart DiseasesHome environmentHumanIleusImmunoprecipitationIn VitroInfectionInformation DistributionInheritedInstitutionIowaKnock-in MouseKnock-outLaboratoriesLeadLungLung diseasesMass Spectrum AnalysisMeconiumMethodologyMethodsMissionModelingMonoclonal Antibody R24MusNational Heart, Lung, and Blood InstituteNeonatalNewborn InfantOrganOther GeneticsOutcomePathogenesisPatientsPeer ReviewPharmaceutical PreparationsPhenotypePliabilityPreparationPrimary Ciliary DyskinesiasProcessProteinsProteomicsProtocols documentationPulmonary EmphysemaReagentResearchResearch PersonnelResourcesRespiratory Tract InfectionsSamplingServicesSourceSpecies SpecificitySpecimenStagingStem cellsTechnologyTestingTissue ModelTissue SampleTissuesTrainingTransgenic OrganismsTranslational ResearchUniversitiesVX-770Viral VectorWestern BlottingWithdrawalWorkXenograft procedureabstractingalpha 1-Antitrypsinalpha 1-Antitrypsin Deficiencybaseclinical carecostcost effectivecystic fibrosis patientsgene therapygenome annotationhuman diseaseimprovedinformation gatheringinterestmeetingsmouse modelmutantpregnantpromoterpublic health relevancerecombinant virusrepositoryresearch studysample collectionsomatic cell nuclear transfertherapy developmenttoolweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Animal models of human disease are critical for translational research aimed at dissecting disease mechanisms and for developing new therapies. The mouse has been invaluable in this effort, but for many diseases this species fails to model the human phenotype. This is particularly evident in the cases of human lung diseases such as cystic fibrosis (CF), alpha-1 antitrypsin (AAT) deficiency, and primary ciliary dyskinesia (PCD). The basis for this species-specificity in disease susceptibility relates to both differences
in lung anatomy and cell biology, and the genetic divergence of mice and humans. Recent advances in the field of animal modeling have placed the domestic ferret at the forefront of new genetically pliable species for modeling human diseases. First, we have developed methods for generating knockout, knock-in, and transgenic ferrets that utilize somatic cell nuclear transfer (SCNT). Second, the ferret genome was recently sequenced and is now publically accessible, providing the information needed to interrogate the genetic suitability of the ferret to model a particular disease, generate gene-targeting constructs, and rapidly generate research tools for studies in this species. As proof of concept, cystic fibrosis transmembrane conductance regulator (CFTR) knockout ferrets have been generated and found to model aspects of multi-organ disease (including spontaneous lung infections) seen in CF patients. Additionally, transgenic ferrets that express fCFTR specifically in the gut (under the direction of the FABPi promoter) have been generated and shown to correct the meconium ileus phenotype in newborn CF ferrets. This R24 resource proposal seeks to create a Center that provides services for ferret disease modeling, with a focus on the distribution of CF ferret resources and the creation of new ferret models of lung disease and of other diseases of NHLBI interest. Other focuses of this proposal will be to provide training in the use of ferrets for research, provide services for alternative in vitro and ex vivo airway models, and promote information exchange with the community through a web site that catalogs and distributes "tool-box" resources of general use for research in the ferret (antibodies, cDNAs, viral vectors, primary airway cells, improved genome annotation files for omics research). Strategic goals of this application will be to expand the number of ferret disease models available to the research community, allow for broad and cost-effective usage of CF ferret models, and build a self-sustaining business model for ongoing function of the Center past the five years of this proposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of Submucosal Gland Stem Cells in the Airway
-
批准号:10516449
-
项目类别:
-
资助金额:$74.51万
-
财政年份:2022
-
负责人:JOHN F ENGELHARDT
-
依托单位:
National Ferret Research and Resource Institute (NFRRI) at University of Iowa
-
批准号:10596901
-
项目类别:
-
资助金额:$797.5万
-
财政年份:2022
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Biology of Submucosal Gland Stem Cells in the Airway
-
批准号:10649543
-
项目类别:
-
资助金额:$70.18万
-
财政年份:2022
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:10599931
-
项目类别:
-
资助金额:$147.99万
-
财政年份:2021
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:10397094
-
项目类别:
-
资助金额:$147.99万
-
财政年份:2021
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10470338
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10677622
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10248531
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
-
批准号:10024668
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2020
-
负责人:JOHN F ENGELHARDT
-
依托单位:
National Ferret Resource and Research Center on Lung Disease
-
批准号:9283593
-
项目类别:
-
资助金额:$80.96万
-
财政年份:2014
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:8769764
-
项目类别:
-
资助金额:$152.34万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:9110992
-
项目类别:
-
资助金额:$151.16万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:9312250
-
项目类别:
-
资助金额:$151.16万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:8529523
-
项目类别:
-
资助金额:$123.17万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:8385023
-
项目类别:
-
资助金额:$131.43万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
-
批准号:9043453
-
项目类别:
-
资助金额:$1.36万
-
财政年份:2012
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8462292
-
项目类别:
-
资助金额:$54.56万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8150246
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8656409
-
项目类别:
-
资助金额:$55.06万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
rAAV-directed gene therapy to the lung in cystic fibrosis ferret models
-
批准号:8293174
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2011
-
负责人:JOHN F ENGELHARDT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: